This Collection aims to explore the complex interplay between structural variants (SVs) and epigenomic modifications that shape the human genome’s architecture and functionality. While structural variants - such as copy number variations, translocations, and inversions - can directly influence gene dosage and disrupt regulatory regions, epigenomic modifications, including DNA methylation and histone modifications, further refine the genomic landscape. Together, these variations play essential roles not only in developmental disorders but also in a wide range of human traits and diseases.
This Collection invites cutting-edge research and comprehensive reviews that examine how these genomic and epigenomic alterations contribute to diverse clinical outcomes. We are especially interested in studies that reveal novel mechanisms by which structural and epigenomic variants interact, influence genome organization, and impact gene expression and cellular functions across various tissues and developmental stages. This broader approach allows us to understand the role of genomic architecture beyond developmental delays and malformations, encompassing other complex diseases and traits affected by genome variability.
Objectives
1. To characterize the impact of structural and epigenomic variants on genome organization, gene regulation, and cellular functions, thereby enhancing our understanding of genomic architecture's role in health and disease.
2. To investigate the contribution of genomic and epigenomic variability in the pathogenesis of developmental disorders, complex traits, and other diseases, with a focus on identifying common and unique mechanisms.
3. To explore the interplay between structural and epigenomic variants, examining how they collectively shape phenotypic outcomes and susceptibility to diseases.
4. To promote cross-disciplinary approaches that integrate genomics, epigenomics, bioinformatics, and clinical studies, fostering a holistic view of genome function and variability.
5. To encourage the development of innovative methodologies for detecting and interpreting structural and epigenomic variants, aiming to improve diagnostics, prognostics, and personalized therapeutic strategies.
By bringing together a more comprehensive body of work, this Collection aspires to advance our understanding of how structural and epigenomic variability contribute to the functional landscape of the human genome, offering insights into normal development and disease processes.